Enzo Biochem, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Details) - Schedule of assumptions used to fair value options granted

Stockholders' Equity (Details) - Schedule of assumptions used to fair value options granted - $ / shares	12 Months Ended
	Jul. 31, 2018	Jul. 31, 2017	Jul. 31, 2016
Stockholders' Equity (Details) - Schedule of assumptions used to fair value options granted [Line Items]
Options Granted (in Shares)	415,580	493,996	495,473
Exercise Price (in Dollars per share)	$ 5.57	$ 7.07	$ 4.48
FMV of options Granted/Per Share (in Dollars per share)	$ 1.91	$ 2.45	$ 1.56
Grant Date 7/31/18 [Member]
Stockholders' Equity (Details) - Schedule of assumptions used to fair value options granted [Line Items]
Options Granted (in Shares)	170,000
Exercise Price (in Dollars per share)	$ 4.42
Term (years)	5 years
Vesting Period (years)	2 years
FMV of options Granted/Per Share (in Dollars per share)	$ 1.53
Expected Life (years)	3 years 3 months
Expected Volatility	44.88%
Interest Rate	2.78%
Grant Date 7/31/18 [Member]
Stockholders' Equity (Details) - Schedule of assumptions used to fair value options granted [Line Items]
Options Granted (in Shares)	115,000
Exercise Price (in Dollars per share)	$ 4.42
Term (years)	5 years
Vesting Period (years)	3 years
FMV of options Granted/Per Share (in Dollars per share)	$ 1.61
Expected Life (years)	3 years 6 months
Expected Volatility	45.92%
Interest Rate	2.79%
Grant Date 7/5/18 [Member]
Stockholders' Equity (Details) - Schedule of assumptions used to fair value options granted [Line Items]
Options Granted (in Shares)	10,000
Exercise Price (in Dollars per share)	$ 5.52
Term (years)	5 years
Vesting Period (years)	3 years
FMV of options Granted/Per Share (in Dollars per share)	$ 2.02
Expected Life (years)	3 years 6 months
Expected Volatility	46.14%
Interest Rate	2.67%
Grant Date 5/31/18 [Member]
Stockholders' Equity (Details) - Schedule of assumptions used to fair value options granted [Line Items]
Options Granted (in Shares)	5,000
Exercise Price (in Dollars per share)	$ 6.50
Term (years)	5 years
Vesting Period (years)	3 years
FMV of options Granted/Per Share (in Dollars per share)	$ 2.34
Expected Life (years)	3 years 6 months
Expected Volatility	45.52%
Interest Rate	2.09%
Grant Date 1/5/18 [Member]
Stockholders' Equity (Details) - Schedule of assumptions used to fair value options granted [Line Items]
Options Granted (in Shares)	110,580
Exercise Price (in Dollars per share)	$ 8.36
Term (years)	5 years
Vesting Period (years)	2 years
FMV of options Granted/Per Share (in Dollars per share)	$ 2.71
Expected Life (years)	3 years 3 months
Expected Volatility	42.85%
Interest Rate	2.09%
Grant Date 1/2/18 [Member]
Stockholders' Equity (Details) - Schedule of assumptions used to fair value options granted [Line Items]
Options Granted (in Shares)	5,000
Exercise Price (in Dollars per share)	$ 8.25
Term (years)	5 years
Vesting Period (years)	3 years
FMV of options Granted/Per Share (in Dollars per share)	$ 2.76
Expected Life (years)	3 years 6 months
Expected Volatility	42.59%
Interest Rate	2.07%
Grant Date 1/5/17 [Member]
Stockholders' Equity (Details) - Schedule of assumptions used to fair value options granted [Line Items]
Options Granted (in Shares)		264,896
Exercise Price (in Dollars per share)		$ 7.07
Term (years)		5 years
Vesting Period (years)		2 years
FMV of options Granted/Per Share (in Dollars per share)		$ 2.40
Expected Life (years)		3 years 3 months
Expected Volatility		46.28%
Interest Rate		1.48%
Vested Shares at 7/31/2018 (in Shares)		132,448
Grant Date 1/5/17 [Member]
Stockholders' Equity (Details) - Schedule of assumptions used to fair value options granted [Line Items]
Options Granted (in Shares)		229,100
Exercise Price (in Dollars per share)		$ 7.07
Term (years)		5 years
Vesting Period (years)		3 years
FMV of options Granted/Per Share (in Dollars per share)		$ 2.48
Expected Life (years)		3 years 6 months
Expected Volatility		45.85%
Interest Rate		1.54%
Vested Shares at 7/31/2018 (in Shares)		66,533
Grant Date 3/14/16 [Member]
Stockholders' Equity (Details) - Schedule of assumptions used to fair value options granted [Line Items]
Options Granted (in Shares)			112,000
Exercise Price (in Dollars per share)			$ 4.35
Term (years)			5 years
Vesting Period (years)			2 years
FMV of options Granted/Per Share (in Dollars per share)			$ 1.46
Expected Life (years)			3 years 3 months
Expected Volatility			46.13%
Interest Rate			1.19%
Vested Shares at 7/31/2018 (in Shares)			112,000
Grant Date 3/14/16 [Member]
Stockholders' Equity (Details) - Schedule of assumptions used to fair value options granted [Line Items]
Options Granted (in Shares)			191,600
Exercise Price (in Dollars per share)			$ 4.35
Term (years)			5 years
Vesting Period (years)			3 years
FMV of options Granted/Per Share (in Dollars per share)			$ 1.57
Expected Life (years)			3 years 6 months
Expected Volatility			48.14%
Interest Rate			1.24%
Vested Shares at 7/31/2018 (in Shares)			77,865
Grant Date 6/16/16 [Member]
Stockholders' Equity (Details) - Schedule of assumptions used to fair value options granted [Line Items]
Options Granted (in Shares)			2,000
Exercise Price (in Dollars per share)			$ 5.61
Term (years)			5 years
Vesting Period (years)			2 years
FMV of options Granted/Per Share (in Dollars per share)			$ 1.88
Expected Life (years)			3 years 3 months
Expected Volatility			46.64%
Interest Rate			0.85%
Vested Shares at 7/31/2018 (in Shares)			2,000
Grant Date 1/6/16 [Member]
Stockholders' Equity (Details) - Schedule of assumptions used to fair value options granted [Line Items]
Options Granted (in Shares)			189,873
Exercise Price (in Dollars per share)			$ 4.66
Term (years)			5 years
Vesting Period (years)			2 years
FMV of options Granted/Per Share (in Dollars per share)			$ 1.65
Expected Life (years)			3 years 3 months
Expected Volatility			48.60%
Interest Rate			1.31%
Vested Shares at 7/31/2018 (in Shares)			189,873